SCHEMBL6161702

SCHEMBL6161702

CCOC(=NNc1ccc(Cl)cc1Cl)C(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
ALDH1A1 P00352 2/20 0.52
KMT2A Q03164 4/20 0.49
MEN1 O00255 2/20 0.49
HPGD P15428 2/20 0.49
USP2 O75604 1/20 0.49
ABCB1 P08183 1/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 4/20 0.45
LMNA P02545 3/20 0.45
THRB P10828 1/20 0.45
RAB9A P51151 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
PSMD14 O00487 1/20 0.44
AGTR1 P30556 1/20 0.44
OPRK1 P41145 1/20 0.44
HKDC1 Q2TB90 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10056749 0.85 ABCB1 (0.53) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL502388 0.85 ABCB1 (0.53) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL502387 0.85 ABCB1 (0.53) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL5817853 0.84 ABCB1 (0.60) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL5817856 0.84 ABCB1 (0.60) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL14139923 0.84 ABCB1 (0.52) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL4404099 0.84 ABCB1 (0.52) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL8687191 0.79 LMNA (0.46) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL14141483 0.78 KMT2A (0.43) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL7826269 0.78 MAPT (0.50) MAPTALDH1A1KMT2AHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0832065-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed